Skip to main content
NCBI home page
AAPS PharmSci logoLink to AAPS PharmSci
. 2002 Oct 15;4(4):119–125. doi: 10.1208/ps040433

Evolving importance of biologics and novel delivery systems in the face of microbial resistance

Terry L Bowersock 1,✉
PMCID: PMC2751322  PMID: 12646005

Abstract

Methods to control infectious diseases in livestock are growing in importance. As the size of the average farm increases-for poultry, dairy and beef cattle, swine, and fish-the risk of rapid spread of infectious diseases increases as well. This increases the need for alternative methods of control of infectious agents. Improvements in specific immunogens, adjuvants, and delivery systems are needed to meet the demand for vaccines to ensure a healthy and safe meat supply. This article explores the challenges, trends, and recent advances in the control of infectious diseases through the use of biologics.

Keywords: biologics, vaccines, animal health, novel delivery systems

References

  • 1.Prescott JF, Dowling PM. Agriculture's role in managing antimicrobial resistance: conference report. Can Vet J. 2000;41:191–197. [PMC free article] [PubMed] [Google Scholar]
  • 2.Aherne F. Antibiotics-Pro or Con? International Pigletter. 2001;21:55–56. [Google Scholar]
  • 3.Levy SB. Multidrug resistance-sign of the times. N Engl J Med. 1998;338:1376–1378. doi: 10.1056/NEJM199805073381909. [DOI] [PubMed] [Google Scholar]
  • 4.The Changing Face of the Beef Industry. Cattle Fax. Jan. 2002; Available at: www.cattle-fax.org
  • 5.Ferber D. Drugless chickens make for healthier people. ScienceNow. December 19, 2001. Available at: http://sciencenow.sciencemag.org/cgi/content/full/2001/1219/3
  • 6.National Chicken Council. Antibiotic treatment surges in Denmark as growth promotion ends. December 2001; Available at: www.svs.dk/uk/Organization/Frm_org.htm
  • 7.Vaccination of Cattle Against Respiratory Disease Pathogens in U.S. Feedlots. Info Sheet. Washington, DC: Government Printing Office; 2000. [Google Scholar]
  • 8.Ferber D. Superbugs on the hoof? Science. 2000;2889:792–794. doi: 10.1126/science.288.5467.792. [DOI] [PubMed] [Google Scholar]
  • 9.Dho-Moulin M, Fairbrother JM. Avian pathogenic Escherichia coli (APEC) Veter Res. (France) 1999;30:299–316. [PubMed] [Google Scholar]
  • 10.Chapman PA, Ellin M, Ashton R, Shafique W. Comparison of culture, PCR and immunoassays for detecting Escherichia coli 0157 following enrichment culture and immunomagnetic separation performed on naturally contaminated raw meat products. Int J Food Microbiol. 2001;68:11–20. doi: 10.1016/S0168-1605(01)00464-0. [DOI] [PubMed] [Google Scholar]
  • 11.Wang H, Li Y, Slavik MF. Efficacy of cetylpyridinium chloride in immersion treatment for reducing populations of pathogenic bacteria on fresh-cut vegetables. J Food Prot. 2001;64:2071–2074. doi: 10.4315/0362-028x-64.12.2071. [DOI] [PubMed] [Google Scholar]
  • 12.Kramer JM, Frost JA, Bolton FJ, Wareing DR. Campylobacter contamination of raw meat and poultry at retail sale: identification of multiple types and comparison with isolates from human infection. J Food Prot. 2000;63:1654–1659. doi: 10.4315/0362-028x-63.12.1654. [DOI] [PubMed] [Google Scholar]
  • 13.Grave K, Lingaas E, Bangen M, Ronning M. Surveillance of the overall consumption of antibacterial drugs in humans, domestic animals and farmed fish in Norway in 1992 and 1996. J Antimicrob Chemother. 1999;4:243–252. doi: 10.1093/jac/43.2.243. [DOI] [PubMed] [Google Scholar]
  • 14.Bilic V, Lipej Z, Valpotic I, Habrun B, Humski A, Njari B. Mycoplasmal pneumonia in pigs in Croatia: first evaluation of a vaccine in fattening pigs. Acta Veterinaria Hungarica. 1996;44:287–293. [PubMed] [Google Scholar]
  • 15.Grand A, Kobisch M. Comparison of the effects of vaccination and pulse medication in a pig herd infected with Mycoplasma hyopneumoniae. Veter Res. (Paris) 1996;27:241–253. [PubMed] [Google Scholar]
  • 16.Roof MB, Doitchinoff DD. Safety, efficacy, and duration of immunity induced in swine by use of an avirulent live Salmonella choleraesuiscontaining vaccine. Am J Vet Res. 1995;56:39–44. [PubMed] [Google Scholar]
  • 17.Methner U, Barrow PA, Berndt A, Steinbach G. Combination of vaccination and competitive exclusion to prevent salmonella colonization in chickens: experimental studies. J Food Microbiol. 1999;49:35–42. doi: 10.1016/S0168-1605(99)00051-3. [DOI] [PubMed] [Google Scholar]
  • 18.Zhang-Barber L, Turner AK, Barrow PA. Vaccination for control of salmonella in poultry. Vaccine. 1999;17:2538–2545. doi: 10.1016/S0264-410X(99)00060-2. [DOI] [PubMed] [Google Scholar]
  • 19.Slauch JM, Mahan MJ, Mekalanos JJ. In vivo expression technology for selection of bacterial genes specifically induced in host tissues. Methods Enzymol. 1994;235:481–492. doi: 10.1016/0076-6879(94)35164-3. [DOI] [PubMed] [Google Scholar]
  • 20.Shea JE, Hensel M, Gleeson C, Holden DW. Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc Natl Acad Sci USA. 1996;93:2593–2597. doi: 10.1073/pnas.93.6.2593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Chatfield SN, Strahan K, Pickard D, Charles IG, Hormaeche CE, Dougan G. Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Microb Pathog. 1992;12:145–151. doi: 10.1016/0882-4010(92)90117-7. [DOI] [PubMed] [Google Scholar]
  • 22.Chatfield SN, Roberts M, Dougan G, Hormaeche C, Khan CM. The development of oral vaccines against parasitic diseases utilizing live attenuated Salmonella. Parasitology. 1995;110:17–24. doi: 10.1017/s0031182000001451. [DOI] [PubMed] [Google Scholar]
  • 23.Bowersock TL, Martin S. Vaccine delivery to animals. Adv Drug Deliv Rev. 1999;38:167–194. doi: 10.1016/S0169-409X(99)00015-0. [DOI] [PubMed] [Google Scholar]
  • 24.Zhao Z, Leong KW. Controlled delivery of antigens and adjuvants in vaccine development. J Pharm Sci. 1996;85:1261–1270. doi: 10.1021/js9602812. [DOI] [PubMed] [Google Scholar]
  • 25.Estuningsih SE, Smooker PM, Wiedosari E, et al. Evaluation ofo antigens of Fascioloa gigantica as vaccines against tropical fasciolosis in cattle. Int J Parasitol. 1997;27:1419–1428. doi: 10.1016/S0020-7519(97)00096-9. [DOI] [PubMed] [Google Scholar]
  • 26.Krieg AM, Yi AK, Matson S, et al. CpG motifs in bacterial DNA trigger B-cell activation. Nature. 1995;374:546–549. doi: 10.1038/374546a0. [DOI] [PubMed] [Google Scholar]
  • 27.Sundquist B, Lovgren K, Morein B. Influenza virus ISCOMS, antibody response in animals. Vaccine. 1988;6:49–53. doi: 10.1016/0264-410X(88)90014-X. [DOI] [PubMed] [Google Scholar]
  • 28.Mumford JA, Jessett DM, Rollinson EA, Hannant D, Draper ME. Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines. Vet Rec. 1994;134:158–162. doi: 10.1136/vr.134.7.158. [DOI] [PubMed] [Google Scholar]
  • 29.Pizza M, Giuliani MM, Fontana MR, et al. Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine. 2001;19:2534–2541. doi: 10.1016/S0264-410X(00)00553-3. [DOI] [PubMed] [Google Scholar]
  • 30.Freytag LC, Clements JD. Bacterial toxins as mucosal adjuvants. Curr Top Microbiol Immunol. 1999;2356:215–236. doi: 10.1007/978-3-642-59951-4_11. [DOI] [PubMed] [Google Scholar]
  • 31.Mrsny RJ, Daugherty AL, McKee ML, Fitzgerald DJ. Bacterial toxins as tools for mucosal vaccination. Drug Discov Today. 2001;7:247–258. doi: 10.1016/S1359-6446(01)02139-0. [DOI] [PubMed] [Google Scholar]
  • 32.Bowersock TL, Shalaby WSW, Levy M, et al. Evaluation of an orally administered vaccine, sing hydrogels containing bacterial exotoxins of Pasteurella haemolytica, in cattle. Am J Vet Res. 1994;55:502–509. [PubMed] [Google Scholar]
  • 33.Weng CN, Tzan YL, Liu SD, Lin SY, Lee CJ. Protective effects of an oral microencapsulated Mycoplasma hyopneumoniae vaccine against experimental infection in pigs. Res Vet Sci. 1992;53:42–46. doi: 10.1016/0034-5288(92)90082-d. [DOI] [PubMed] [Google Scholar]
  • 34.Liao CW, Cheng IC, Heh KS, Lin FY, Weng CN. Release characteristics of microspheres prepared by co-spray drying Actinobacillus pleuropneumoniae antigens and aqueous ethylcellulose dispersion. J Microencapsul. 2001;18:285–297. doi: 10.1080/02652040010019442. [DOI] [PubMed] [Google Scholar]
  • 35.Hensel A, Stockhole-Zurwieden N, Petzoldt K, Lubitz W. Oral immunization of pigs with viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces pulmonary and systemic antibodies against homologous aerosol challenge. Infect Immun. 1995;63:3048–3053. doi: 10.1128/iai.63.8.3048-3053.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Lee RW, Strommer J, Hodgins D, Shewen PE, Niu Y, Lo RY. Towards development of an edible vaccine against bovine pneumonic pasteurellosis using transgenic white clover expressing a Mannheimia haemolytica A 1 leukotoxin in 50 fusion protein. Infect Immun. 2001;69:5786–5793. doi: 10.1128/IAI.69.9.5786-5793.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Hood EE, Witcher DR, Maddock S, et al. Commercial production of avidin from transgenic malze: characterization of transformant, production, processing, extraction and purification. Mol Breed. 1998;4:301–312. doi: 10.1023/A:1009622429758. [DOI] [Google Scholar]
  • 38.Bowersock TL, Martin S. Controlled release vaccines in veterinary medicine. In: Rathbone MJ, Gurny R, editors. Controlled Release Veterinary Drug Delivery: Biological and Pharmaceutical Considerations. Amsterdam, The Netherlands: Elsevier; 2000. pp. 269–310. [Google Scholar]
  • 39.Nally JE, Artiushin S, Sheoran AS, et al. Induction of mucosal and systemic antibody specific for SeMF3 of Streptococcus equi by intranasal vaccination using a sucrose acetate isobutyrate based delivery system. Vaccine. 2000;19:492–497. doi: 10.1016/S0264-410X(00)00187-0. [DOI] [PubMed] [Google Scholar]
  • 40.Singh M, Briones M, O'Hagan DT. A novel bioadhesive intranasal delivery system for inactivated influenza vaccines. J Control Release. 2001;70:267–276. doi: 10.1016/S0168-3659(00)00330-8. [DOI] [PubMed] [Google Scholar]
  • 41.Opdebeeck JP, Tucker IG. A cholesterol implant used as delivery system to immunize mice with bovine serum albumin. J Control Release. 1993;23:271–279. doi: 10.1016/0168-3659(93)90008-S. [DOI] [Google Scholar]
  • 42.Ulmer JB, Donnelly JJ, Parker SE, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 1993;259:1745–1749. doi: 10.1126/science.8456302. [DOI] [PubMed] [Google Scholar]
  • 43.Cox GJM, Zamb TJ, Babiuk LA. Bovine herpesvirus 1: immune responses in mice and cattle infected with plasmid DNA. J Virol. 1993;67:5664–5667. doi: 10.1128/jvi.67.9.5664-5667.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Krishnan BR. Current status of DNA vaccines in veterinary medicine. Adv Drug Deliv Rev. 2000;43:3–11. doi: 10.1016/S0169-409X(00)00073-9. [DOI] [PubMed] [Google Scholar]
  • 45.Chen SC, Jones DH, Fynan EF, et al. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J Virol. 1998;72:5757–5761. doi: 10.1128/jvi.72.7.5757-5761.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Halbur P, Thanawongnuwech R, Brown G, et al. Efficacy of antimicrobial treatments and vaccination regimens for control of porcine reproductive and respiratory syndrome virus and Streptococcus suis coinfection of nursery pigs. J Clin Microbiol. 2000;38:1156–1160. doi: 10.1128/jcm.38.3.1156-1160.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Greene CE, Schultz RD, Ford RB. Canine vaccination. Vet. Clin North Am Small Anim Pract. 2001;31:473–494. doi: 10.1016/S0195-5616(01)50603-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Ford RB. Vaccines and vaccinations: the strategic issues. Vet Clin North Am Small Anim Pract. 2001;31:439–453. doi: 10.1016/s0195-5616(01)50601-4. [DOI] [PubMed] [Google Scholar]
  • 49.Shao ZJ. Aquaculture pharmaceuticals and biologicals: current perspectives and future possibilities. Adv Drug Deliv Rev. 2001;50:229–243. doi: 10.1016/S0169-409X(01)00159-4. [DOI] [PubMed] [Google Scholar]
  • 50.Oirschot JT. Present and future of veterinary viral vaccinology: a review. Vet Q. 2001;23:100–108. doi: 10.1080/01652176.2001.9695094. [DOI] [PubMed] [Google Scholar]

Articles from AAPS PharmSci are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES